JD.Com Inc vs Novartis AG — how do they compare? JD.Com Inc trades at $31.44 (market cap $44.04B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 6.7× JD.Com Inc's market cap, and JD.Com Inc pays the higher dividend (3.13%). Which is the better fit depends on your goals.
| JD | NVS | |
|---|---|---|
Market Cap | $44.04B | $295.37B |
Sector | Consumer Cyclical | Health |
52-Week High | $36.17 | $168.62 |
52-Week Low | $25.19 | $119.31 |
Enterprise Value | $30.10B | $336.69B |
Dividend Yield | 3.13% | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →